Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia

Malcolm J. Sheardown, Elsebet Ø. Nielsen, Anker Jón Hansen et al. · Science · 1990 · 1.1K citations

Medicine, Neuroscience, Pharmacology +16

Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A

Kathryn M. Partin, DK Patneau, C.A. Winters et al. · Neuron · 1993 · 585 citations

Medicine, Neuroscience, Pharmacology +16

A simple apparatus for studying the release of neurotransmitters from synaptosomes

Maurizio Raiteri, Francesco Angelini, Giulio Levi · European Journal of Pharmacology · 1974 · 458 citations

Life Sciences, Biochemistry, Neuroscience +12

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

Vernon R. J. Clarke, Barbara A. Ballyk, Ken H. Hoo et al. · Nature · 1997 · 416 citations

Life Sciences, Neurobiology, Neuroscience +14

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Sean D. Donevan, Michael A. Rogawski · Neuron · 1993 · 359 citations

Medicine, Neuroscience, Pharmacology +15